Dose Finding Study in COPD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The primary objective of this study is to determine the optimum dose of BEA 2180 BR inhalation solut ion delivered by the Respimat ? inhaler once daily for four weeks in patients with COPD.
Epistemonikos ID: 300d7cfb25755c23b4b577fe673ac5c7234d8c9b
First added on: May 04, 2024